Nuevocor
Entry
2025
Hold
1yr
Status
Active
Who owns Nuevocor?
Nuevocor is a French Biotech company, currently owned by Angelini Ventures since 2025 and Boehringer Ingelheim Venture Fund.
Hand-verified · updated 2026-04-21
Open JSON · CC-BYMost recent investor
Angelini VenturesAngelini Ventures · 2022 · Life Sciences VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2021 · present
Angelini VenturesActive
2025 · present(1yr) · Angelini Ventures · 2022 · Life Sciences VC
More from Angelini Ventures
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Nuevocor?
Nuevocor is currently owned by Angelini Ventures and Boehringer Ingelheim Venture Fund, through Angelini Ventures, since 2025.
When did Angelini Ventures and 1 other acquire Nuevocor?
Angelini Ventures and 1 other acquired Nuevocor in 2025.
Who has owned Nuevocor over time?
Nuevocor has been through 2 private-equity ownership periods: Boehringer Ingelheim Venture Fund · via Boehringer Ingelheim Venture Fund · since 2021; Angelini Ventures · via Angelini Ventures · since 2025.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue